Loading...
•
Mar 31, 2024
IRadimed Q1 2024 Earnings Report
IRadimed achieved record revenue and increased operating income compared to the same period last year.
Key Takeaways
IRadimed Corporation reported record revenue of $17.6 million for Q1 2024, a 13.7% increase compared to Q1 2023. GAAP diluted EPS was $0.32, and non-GAAP diluted EPS was $0.36. Operating income increased by 18.5% to $4.7 million.
Record revenue of $17.6 million was reported for the first quarter of 2024.
GAAP diluted EPS was $0.32, and non-GAAP diluted EPS was $0.36 for the first quarter of 2024.
Operating income for the first quarter of 2024 was $4.7 million, an 18.5% increase compared to the same period in 2023.
A regular quarterly cash dividend of $0.15 per common share was declared for the second quarter of 2024.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
For the second quarter of 2024, the Company expects to report revenue of $17.6 million to $17.8 million, GAAP diluted earnings per share of $0.33 to $0.36, and non-GAAP diluted earnings per share of $0.36 to $0.39.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...